Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for ANTI-SEZ6-ANTIKÖRPER-ARZNEIMITTELKONJUGATE UND DEREN VERWENDUNGSMETHODEN
Details for 2019732174
Up to date per 17.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2019732174
Title / Product Name
ANTI-SEZ6-ANTIKÖRPER-ARZNEIMITTELKONJUGATE UND DEREN VERWENDUNGSMETHODEN
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2019732174
EP Publication Number
3710485
E-Number
1376848
Language
EN
PCT Number
US19034701
Publication Date
23.09.2020 A
31.03.2021 B1
Registration Date
31.03.2021
AT Publication Date
15.04.2021
Application Date
30.05.2019
Registration Number
-
Priorities
30.05.2018
US
201862678061 P
IPC
C07K 16/28 20060101AFI20191206BHEP
Maximum Duration of Protection
30.05.2039
Owner
AbbVie Stemcentrx LLC
1 North Waukegan Road
North Chicago, IL 60064-6400
US
Representative
Representative
Babeluk Patentanwälte GmbH
Florianigasse 26/3
1080 Wien
AT
Inventor
LIU, David
495 Loma Vista Terrace
Pacifica, California 94044
US
GAVRILYUK, Julia
3525 Del Mar Heights Road, 1855
San Diego,CA 92130
US
SCHAMMEL, Alexander
25 Glendale Street, Apt. 3
San Francisco, California 94114
US
Information about Fees
Click here to load the fees